$1.65
-0.19-10.33%
Last update: 9:31 AM
15 minutes delayed
Fortress Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fortress Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.73 | $-1.23 | 40.6 % |
Mar 2024 | 2024-05-15 | $-1.03 | $-1.73 | 40.5 % |
Dec 2023 | 2024-03-28 | $-0.53 | $-1.97 | 73.1 % |
Sep 2023 | 2023-11-14 | $-0.94 | $-3.21 | 70.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $14.90M | $14.77M | 0.83 % |
Mar 2024 | 2024-05-15 | $13.03M | $14.13M | -7.78 % |
Dec 2023 | 2024-03-28 | $19.95M | $14.89M | 34.0 % |
Sep 2023 | 2023-11-14 | $34.75M | $14.58M | 138.3 % |
Fortress Biotech (FBIO) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.73, which beat the estimate of $-1.23.
The Actual Revenue was $14.9M, which beat the estimate of $14.8M.
Browse earnings estimates, EPS, and revenue on all stocks.